Efruxifermin (EFX)

Our multi-modal drug, efruxifermin (EFX), holistically confronts the many facets of NASH and is designed to reduce liver fat and inflammation, reverse fibrosis and restore a healthy lipoprotein profile to fight back cardiovascular disease – the number one cause of death for people with NASH.